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SUMMARY
Aphidicolin, a tetracyclic diterpenoid which inhibits the DNA polymerase-ct activities of many eukaryotic cells, inhibited herpes simplex virus growth and DNA synthesis in infected cultures and the activity of the virus DNA polymerase in vitro. A wide range of stable aphidicolin sensitivities was represented amongst a collection of virus strains with no prior exposure to this drug, but viruses with polymerase mutations selected for resistance to phosphonoacetic acid (PAA) or to acycloguanosine typically showed increased sensitivity to aphidicolin. Of 16 unrelated PAA-resistant variants, 7 were hypersensitive to aphidicolin. A number of mutants with temperature-sensitive (ts) lesions in the polymerase gene also showed increased aphidicolin sensitivity (e.g. HSV-I[mP17]tsH) or aphidicolin hypersensitivity (e.g. HSV-I[KOS]tsD9, tsC4). Resistance or hypersensitivity of virus growth and DNA synthesis in vivo were correlated with resistance or hypersensitivity of virus DNA polymerase reactions in vitro. Resistance phenotypes were closely linked to the polymerase gene during recombination with outside markers. Moreover, the selection of aphidicolin-resistant mutants from hypersensitive variants with independent PAA resistance or ts mutations in the polymerase gene could result in co-selection for PAA-sensitive and ts + phenotypes. Confirmation that multiple independent mutations could determine aphidicolin hypersensitivity was obtained by studies of recombination between independent hypersensitive variants. Aphidicolin-resistant recombinant progeny were formed with recombination frequencies (0.4 to 2.6~) compatible with intragenic events. With parental hypersensitive variants which were products of limited PAA selection, or with the ts polymerase mutations, aphidicolin-resistant recombinants were PAA-sensitive and/or ts +. The segregation of other markers (ts, plaque morphology) amongst recombinant progeny permitted the orientation of multiple determinants of PAA resistance and aphidicolin hypersensitivity with respect to other markers in the polymerase gene and in other genes. The nature of residues determined at any one of a constellation of separate sites within the polymerase locus can determine resistance or sensitivity to antiviral drugs and aphidicolin hypersensitivity associated with changes at the polymerase locus facilitates high resolution genetic analysis of this locus.
INTRODUCTION Herpesviruses characteristically specify the synthesis of a novel DNA polymerase activity which is essential for the replication of virus DNA in productively infected cells. For herpes simplex viruses of type l and type 2 (HSV-1, HSV-2) there is now good evidence that t Present address: Department of Pharmacology and Experimental Therapeutics, The Johns Hopkins School of Medicine, Baltimore, Md., 21205, U.S.A. 0022-1317/84/0000-5864 $02.00 © 1984 SGM temperature-sensitive (ts) mutants in the HSV-I complementation groups [1-3] (e.g. HSV-1- [Kos] tsC4 and tsC7 and HSV-I[mP17]tsH) and [1] [2] [3] [4] (e.g. HSV-I[Kos]tsD9 and HSV-I[mP17]-tsH) and in the HSV-2 complementation group [2-3] (e.g. tsB5 and HSV-2[HG52]-ts6; see Schaffer et al., 1978) have lesions in essential components of the virus DNA polymerase (Aron et al., 1975; Purifoy & Powell, 1981) A number of mutations affecting the sensitivity of virus replication to antiviral drugs have also been associated with components of herpesvirus DNA polymerase activities. Thus, the HSV enzyme is normally sensitive to phosphonoacetic acid (PAA) and its congener phosphonoformic acid (Mao et al., 1975 ; Herrin et al., 1977; Erikkson et al., 1980) . Stable mutants resistant to different drug concentrations can be selected and the emergence of highly resistant viruses during multiple passages in the presence of the drug normally involves selection for multiple sequential changes in the resistance of the progenitor virus (Honess & Watson, 1977) . However, independently derived resistant mutants have been shown to specify DNA polymerase activities with increased resistance to PAA in vitro (e.g. Hay & Subak-Sharpe, 1976; Honess & Watson, 1977 ; Derse et al., 1982) , and independently derived mutations to PAA resistance have been located by marker transfer or studies of intertypic recombinants (Chartrand et al., 1979 at or within the locus determining temperature sensitivity of the DNA polymerase activity. In recombination experiments with outside markers, resistance determinants normally co-segregate as single markers with resistant DNA polymerase activity (Honess & Watson, 1977; Honess et al., 1980) . Moreover, the HSV-I[Kos]tsD9 mutant also possesses unselected resistance to PAA and a ts + revertant of this mutant (i.e. DR3) reverted to PAA sensitivity . The tsD9 lesion and its associated PAA resistance are corrected to wild-type phenotypes by ts + sequences from 0.422 to 0.428 map units on the prototype orientation of the genome (Coen et al., 1983b) . The evidence associating dominant determinant(s) of PAA resistance or sensitivity in a component of the virus DNA polymerase is therefore compelling.
The properties of the tsD9 mutation also provide a clear indication that alterations which result in PAA resistance can be of more than one type or at more than one site, since the majority of independently derived PAA-resistant mutants are not temperature-sensitive. In addition, the HSV-I[Kos]PAAr-5 resistance marker is transferred by sequences outside and to the right of the location of the tsD9 lesion (Coen et al., 1983a, b) . Similarly, selection for PAA resistance may result in more than one type of unselected alteration in the resistance to other inhibitors such as acycloguanosine and arabinosyl-adenosine (Coen & Schaffer, 1980; Crumpacker et al., 1980; Schnipper & Crumpacker, 1980; Knopf et al., 1981; Furman et al., 1981 ; Coen et al., 1982; Derse et al., 1982) . However, despite such evidence for heterogeneity in the determinants of PAA resistance the dissection of such determinants by conventional genetic analysis is both complex and tedious, particularly when alterations at more than one of a set of closely linked sites may be determining resistance.
During the course of experiments comparing the action of the tetracyclic diterpenoid, aphidicolin, on the synthesis of DNA in cells infected with HSV and herpesvirus saimiri, we found that a variant of HSV selected for high level resistance to PAA had acquired an unselected hypersensitivity to aphidicolin (O'Hare & Honess, 1983) . In contrast to the analysis of resistance, the hypersensitive phenotype is a very convenient property for genetic analysis. In this paper we present the results of an examination of the aphidicolin resistance and sensitivity of isolates of HSV-1 and HSV-2 and of ts mutants and drug-resistant mutants of these viruses. This examination revealed that aphidicolin hypersensitivity was a relatively common consequence of single, well-separated, mutations within the HSV DNA polymerase locus and, in particular, of mutations selected for PAA resistance.
METHODS

Cells and viruses.
Vero cell monolayers were used for most plaque assays and plaque reduction tests and for all high multiplicity infections. Cultures were grown at 37 °C in Dulbecco's H21 modification of Eagle's tissue culture medium with 10~ newborn calf serum and assays of ts + viruses were normally conducted at 37 °C. For ts mutants a permissive temperature of 34 °C was adopted for all mutants and a non-permissive temperature of 38.8 °C. Some plaque assays were also performed on monolayers of BHK-21 cells or owl monkey kidney cells. The strains and mutants of HSV-1 and HSV-2 are given in Tables 1, 2 and 3 together with some of their relevant properties.
Titrations andplaque-reduction tests. Replicate monolayers of Vero cells (2 × 106 cells in 25 cm 2 tissue culture flasks) were inoculated with an appropriate range of virus dilutions. After an adsorption period of 1 h the inocula were decanted and replaced with culture medium with 5~ calf serum and 0-5~o carboxymethylcellulose and containing the desired concentrations of aphidicolin and PAA (see text). Aphidicolin was dissolved at 1 to 10 mg/ml in dimethyl sulphoxide and diluted directly into tissue culture medium to give concentrations of ~< 15 lag/rot. Phosphonoacetic acid (disodium salt; I.C.N. Pharmaceuticals, Plainview, N.Y., U.S.A.) was dissolved in tissue culture medium and diluted to give final concentrations of 50 lag/ml (for experiments with tsD9) or 75 to 100 lag/ml (for other PAA-resistant viruses) in the overlay medium. Infected monolayers were incubated at 34 °C, 37 °C or 38.8 °C, as appropriate, for 2 to 5 days until the diameters of plaques on the control plates were > 0-5 mm and < 2.0 mm (i.e. 2 days for syn viruses; 4 to 5 days for ts.syn + viruses at 34 °C). Monolayers were fixed with 10~ (v/v) formol saline, stained with crystal violet and the plaques enumerated and classified as syncytial (syn) or non-syncytial (syn +) with the aid of a binocular dissecting microscope.
High multiplicity infections, labelling of infected cultures with [3 H]thymidine and analysis of virus DNA synthesis.
Replicate monolayer cultures of Vero cells were infected with 20 p.f.u./cell of appropriate virus strains or mutants (text) and after 6 to 8 h (ts + viruses at 37 °C) or 8 to 10 h (ts viruses at 34 °C) the growth medium was replaced with medium containing 10 to 20 laCi [Me-3H]thymidine per ml (40 Ci/mmol; Amersham International) for 1 to 2 h. At the end of these labelling intervals, cultures were rinsed thoroughly with cold phosphate-buffered saline and then lysed in buffer containing 0.5~ SDS in 10 mM-Tris-HCl pH 7.6, 2 mM-EDTA and the incorporation of [3H]thymidine into trichloroacetic acid (TCA)-precipitable material determined. Aliquots of these lysates were homogenized by sonication made to 10~ (w/v) TCA and the precipitates which formed after 30 min on ice were collected by filtration through glass-fibre discs (Whatman GF/C) which were washed with 5 ~ TCA, 80~ ethanol and 100 ~ ethanol, dried and the TCA-precipitable [3H]thymidine-derived radioactivity measured by scintillation spectrophotometry. To determine the proportion of total incorporation of [3H]thymidine which was into virus DNA in infected cells, samples of cultures labelled in the absence of inhibitors and in the presence of 0,25 I_Lg/ml and 0-5 ~g/ml aphidicolin were separated on caesium chloride density gradients. Cell Iysates (above) were digested with proteinase K (100 ~ag/ml for 6 h at 37 °C), extracted twice with equal volumes of a mixture of phenol/chloroform/isoamyl alcohol (24 : 24 : 1), twice with chloroform and the DNA precipitated from the aqueous phase by the addition of 2vol. ethanol (-20°C) and 0.1 vol. 1 M-sodium acetate. The DNA was redissolved in buffer containing 10 mM-Tris H C1 pH 7.6 and 2 mM-EDTA and made to a density of 1-717 g/ml (refractive index 1-4015) by the addition of caesium chloride. Samples were sedimented to equilibrium in a Beckman vertical rotor (5 ml vol. ; 18 to 36 h at 35000 rev/min) and the distribution of labelled DNA measured by TCA precipitation of aliquots from fractions harvested from the bottom of the tube. Under these conditions virus and cellular DNAs are well separated (peaks at 1/3 and 2/3 of distance from the bottom of the tube) and in the experiments illustrated more than 86~ of the incorporation into infected cultures over the labelling intervals chosen ( Fig. 1) was into virus DNA.
Preparation and assay of extracts ofDNA polymerase activity. Vero cell monolayers in 80 oz roller bottles or 75 cm 2 flasks were infected with 5 p.f.u./cell of the appropriate virus strain. After an adsorption period of 2 h, inocula were decanted and replaced with medium containing 2 ~ calf serum. Cultures were incubated at 37 °C until 16 h after infection, the growth medium was then decanted and the cultures washed in ice-cold phosphate-buffered saline. The washed cells were detached from the culture vessels using rubber policemen, pelleted by bench centrifugation (1500 rev/min for 10 min) and resuspended in buffer containing 20 mM-Tris-HC1 pH 7.8, 2 mM-2mercaptoethanol and 50~ glycerol, at 0.2 x 107 to 1,0 x 107 cells/ml. The cell suspensions were then disrupted by sonication and stored at -20 °C. DNA polymerase assays were carried out at 37 °C in 0-2 ml reaction mixtures containing the appropriate concentrations ofaphidicolin in 50 mM-Tris HCI pH 7-8, 100 mM-(NH,)2SO4, 20 mM-KC1, 5 mM-MgCI2, 6 mM-2-mercaptoethanol, 0-2 mM each of dCTP, dATP, dGTP, 0.05 mM-dTTP, 0-5 mM-EDTA, 0.5 laCi [3H]dTTP (42 to 48 Ci/mmol, Amersham International) and 75 lag 'activated' salmon sperm DNA per assay. Reactions were terminated by the addition of 0.2 ml cold 20~ (w/v) TCA. Precipitable material was then collected by filtration onto glass fibre discs (GF/C) and washed sequentially with 10~ (w/v) TCA, 5 ~ (w/v) TCA and 100~ ethanol. Discs were then dried, placed in scintillation fluid and radioactivity counted in a Beckman LS7000 liquid scintillation spectrophotometer.
RESULTS
The aphidicolin sensitivity of recent isolates of HSV-1 and of a collection of laboratory strains of HSV-1 and HSV-2
Results from a series of experiments estimating the relative aphidicolin sensitivity of recent isolates of HSV-1 (S11 to $49) and of a collection of relatively well characterized laboratory strains with varied passage histories are given in original laboratory strains (i.e. Table 1: lines 7 to 11 , 15, 17, 21, 22, 25, 28 and 29) had been exposed to aphidicolin prior to measurements of their sensitivity in these plaque-reduction tests. There was nevertheless a considerable range of aphidicolin sensitivities represented amongst this population of viruses (e.g. for HSV-1 [$36], line 3, 0-3 ~ of plaques survive at 0.5 gg whereas for HSV-1 IF 1 ], line 7, 89 ~o of the control plaque numbers were recorded in the presence of 0-5 gg aphidicolin per ml), and on average the recent isolates were more sensitive than the established laboratory strains.
Aphidicolin resistance phenotypes of recent isolates and of laboratory strains of HS V-1 and HS V-2 and of their PAA-resistant and
ACV-resistant derivatives
Alterations of aphidicotin resistance of ts + viruses by selection for res&tance to PAA or acycloguanosine
The present study was stimulated by the observation that a variant of HSV-I[HFEM] which had been selected for resistance to high concentrations of PAA by multiple sequential passages in the presence of the latter drug (i.e. HSV-I[HFEM]P 18cl) was hypersensitive to aphidicolin relative to its parent strain (Table 1 , lines 17 and 18). We had previously used this PAA-resistant virus in a variety of recombination experiments to transfer the PAA resistance character into other strains and mutants (Honess & Watson, 1977; Honess et al., 1980) . A product of one such cross with HSV-I[B2006] ( Measurements of other variants selected for PAA resistance from independent strains of HSV-1 and HSV-2 and ts mutants of these strains also showed significant increases in sensitivity to aphidicolin relative to their PAA-sensitive parental strains (e.g. Table 1 , lines 22 and 24, lines 25, 26 and 27 ; Table 2 , lines 7 and 8, 12 and 13, 24 and 25, 31 and 32; Table 3 , lines 3 and 4, 6 and 7, 8 and 9). No examples of increases in aphidicolin resistance following PAA selection were noted, even though such mutations could be selected by growth in the presence of aphidicolin (below). If we define an aphidicolin-hypersensitive variant as one in which plaque formation is reduced to less than 0.5 ~o of control values by 0-25 gg/ml aphidicolin then 7 of 16 independently selected PAA-resistant derivatives acquired aphidicolin hypersensitivity concurrently with PAA resistance (underlined in Tables 1 and 2) and all PAA-resistant derivatives of parents which were not themselves aphidicolin-hypersensitive showed some increase in aphidicolin sensitivity. Moreover, viruses which had been selected for resistance to acycloguanosine and which had acquired unselected increases in PAA resistance (Field et al., 1980) also showed significantly increased sensitivity to aphidicolin (Table 1 , compare line 13 with 14 and line 15 with 16). The virus TK-phenotype, or resistance to acycloguanosine and other nucleotide analogues associated with other changes at the TK locus, is not associated with significant changes in aphidicolin sensitivity (Table 1 , lines 11 and 12; lines 11 and 13 and recombination experiments cited above).
Stocks of most aphidicolin-hypersensitive strains normally contained measurable levels of mutants or revertants which were resistant to 0.5 gg/ml aphidicolin. In the populations of HSV-I[HFEM]P18cl used in these experiments these mutants were present at frequencies of 1 x 10 -s to 4 x 10 -s and a number of clones of these mutants were isolated and plaquepurified directly from appropriate virus dilutions titrated in the presence of the inhibitor and thereafter plaque-purified in the absence of the drug. The response of one such resistant virus clone in the plaque reduction test is presented in Table 1 for comparison with its hypersensitive parent (lines 18 and 20). 
Aphidicolin resistance phenotypes of ts mutants of HSV-1 and their PAA-resistant derivatives
Correlations between aphidicolin sensitivity of plaque formation, virus yield, the synthesis of virus DNA in vivo and the virus DNA polymerase activity in vitro
In Fig. 1 the aphidicolin dose-response relationships for the yields of infectious progeny virus (Fig. 1 a) and the synthesis of virus DNA (Fig. 1 b) in cells infected with the aphidicolin-hypersensitive virus, HSV-1 [HFEM]P 18c 1, and an aphidicolin-resistant mutant (Aph r-1) of this virus are compared with the response of the corresponding DNA polymerase activities from extracts of infected cells assayed in vitro (Fig. 1 c) . Resistance and hypersensitivity as assessed by the plaque-reduction tests (Table 1) are clearly correlated with these alternative measures of sensitivity and, in particular, similar drug concentrations are effective in preventing virus DNA synthesis in vivo (Fig. 1 b) and in inhibiting the activity of the virus DNA polymerase in vitro (Fig. Table 2 ) have confirmed the correlation between these different measures of aphidicolin sensitivity. In cells infected with tsD9 virus, DNA synthesis at the permissive temperature (34 °C) was inhibited in a manner virtually indistinguishable from that illustrated for the synthesis of cellular DNA in Fig. 2(b) (not shown).
Effects of ts mutations on aphidicolin sensitivity
Results from a survey of the aphidicolin resistance phenotypes of a representative collection of ts mutants from selected DNA-positive and DNA-negative complementation groups of HSV-1 and HSV-2 relative to their parental strains and PAA-resistant derivatives of these mutants are presented in Tables 2 and 3. Members of HSV-1 group [1-1] are probably mutant in the structural gene for the major virus-specified DNA-binding protein (ICP8; e.g. Conley et al., 1981 ; Weller et al., 1983) , members of group [1-2] are mutant in the • (immediate early) gene for the 175K phosphoprotein, ICP4, and members of groups [1-3] and [1-4] are thought to be mutants in the major polypeptides of the HSV-1 DNA polymerase (Introduction). Members of the HSV-1 group [1-9] are probably in the structural gene for glycoprotein A/B (Manservigi et al., 1977; Sarmiento et al., 1979; Honess et aL, 1980; De Luca et al., 1982) . Mutants in HSV-2 group [2-2] are probably in the gene for the major DNA-binding protein and those in group [2] [3] in a component of the virus DNA polymerase (Dixon et al., 1983; Chartrand et al., 1979 . In addition to the observation that the independently selected PAA-resistant derivatives of ts mutants are invariably of increased aphidicolin sensitivity and are frequently hypersensitive, two other observations merit comment. Firstly, the tsD9 and tsC4 mutants are hypersensitive to aphidicolin without PAA selection. Secondly, in strain [Kos] and in strain [mP17] some mutations from syn ÷ to syn result in a small but significant increase in aphidicolin resistance ( Table 2 , lines 3 and 4) and some other ts mutants have increased aphidicolin sensitivity, but are not aphidicolin-hypersensitive (e.g. ts807 and ts84 respectively). The effect of a subset of mutations in a syn determinant in these virus strains is unexpected. However, it has also been noted in all those is. syn + virus stocks which show significant levels of syn mutants (e.g.
[mPl7]syn +. tsH, [Kos]tsC4; in syn +. tsC4 stocks syn plaques comprised 0.1 to 0.5~ of the population in the absence of the inhibitor but more than 50~ of the surviving plaques at 0.25 ~tg/ml aphidicolin).
Reciprocal co-selection and co-reversion as evidence for the identity or non-identity of ts or PAA resistance determinants as determinants of aphidicolin hypersensitivity
With the exception of the tsD9 mutant, stocks of all the ts mutants contained readily measurable levels of ts + revertants and all aphidicolin-hypersensitive strains showed significant frequencies of mutation or reversion to aphidicolin resistance (i.e. large plaques at 38.8 °C or at 34 °C + 0.3 ~tg/ml aphidicolin). For example, for the tsC4 mutant and for the PAA-resistant variants of tsB5 and tsc75 these frequencies were in the range 5 x 10 -4 to 10-5, whereas for the tsD9 mutant they were < 10 -6. m number of ts + revertants of tsC4 and aphidicolin-resistant mutants from the PAA-resistant variants of tsB5 and tsc75 were identified and isolated directly from appropriate dilutions of previously unselected virus populations assayed at the high temperature (38-8 °C) or at 34 °C in the presence of 0.3 ~tg/ml aphidicolin. These virus clones were then plaque-purified twice by limiting dilutions at 34 °C in the absence of aphidicolin (i.e. under non-selective conditions). The ts ÷ revertant of tsD9 was the DR3 virus isolated and characterized by and aphidicolin-resistant mutants of tsD9 and of tsC4 were isolated from stocks after four (tsD9) or six (tsC4) passages at 34 °C in the presence of 0-25 ~tg/ml aphidicolin and were plaque-purified twice in the presence of 0.25 ~tg/ml aphidicolin at 34 °C. Comparisons of the relative efficiencies of plaque formation of typical clones of these viruses and their parents in the presence of aphidicolin and PAA at permissive and nonpermissive temperatures are summarized in Table 4 .
In the case of tsD9, the ts ÷ revertant (DR3), which was previously shown to have reverted to PAA sensitivity, can be seen to have reverted also to aphidicolin resistance. Moreover, selection for aphidicolin resistance also resulted in unselected changes to a ts ÷ phenotype and to PAA sensitivity. Five clones isolated from the same aphidicolin selected stock behaved in an identical manner. The plaques of the tsD9Aph r-1 variant were, however, somewhat smaller than those of /tO R.W. HONESS AND OTHERS the DR3 variant at the high temperature. The simplest interpretation of these results is that the temperature sensitivity, PAA resistance and aphidicolin hypersensitivity of tsD9 are determined by the same single mutation, that reversion to 'wild-type' phenotypes can only occur by an alteration at the same site but that more than one acceptable change at this site will confer wild-type or pseudo-wild-type phenotypes. In the case of tsC4 the result of selection of the ts + character frequently, but not invariably, results in the co-selection of aphidicolin resistance (five of six clones, including ts ÷ C4cl, as shown) but selection for aphidicolin resistance can occur frequently without co-selection for ts + (e.g. C4P8cl). It appears that the tsC4 mutation may determine aphidicolin hypersensitivity but that the ts mutation and its effect on aphidicolin hypersensitivity can be corrected to a pseudo-wild-type phenotype by changes at more than one alternative site. Results of selection for aphidicolin resistance in the PAA-resistant variants of tsB5 and tsc75 were more straightforward: aphidicolin-resistant mutants normally reverted to PAA sensitivity but retained their ts character (Table 4 ). In contrast, aphidicolin-resistant variants selected from the high-passage PAA-resistant variant, [HFEM]P18cl, retained PAA resistance. The simplest interpretations of these observations are that in the PAA-resistant derivatives of tsc75 and tsB5 the determinant of PAA resistance is also the determinant of aphidicolin hypersensitivity but in the case of [HFEM]P18cl the change determining aphidicolin hypersensitivity is only one of a number of changes contributing to PAA resistance. These interpretations and their corollary, that both PAA resistance and aphidicolin hypersensitivity can be determined by independent changes at many different sites, receive strong support from an analysis of recombination between independent aphidicolin-hypersensitive variants.
Recombination between independent determinants of aphidicolin hypersensitivity and the segregation of unselected markers amongst recombinant progeny
Results from recombination experiments with hypersensitive variants for which co-selection provided evidence for identity of PAA resistance determinants and determinants of aphidicolin hypersensitivity are illustrated in Table 5 . An example of an experiment with the [HFEM]P18c 1 variant, in which selection for aphidicolin resistance did not affect PAA resistance, is given in Table 6 . These examples were chosen since these combinations allowed the syn as well as the ts and PAA resistance markers to be used to deduce linkage relationships to markers outside the polymerase gene.
From Table 5 we may derive the following results for the cross tsB5 x tsD9: (i) A significant fraction of aphidicolin-resistant progeny arise by recombination between the determinants of aphidicolin hypersensitivity of these variants (about 0-43% recombination; resistant recombinants are homogeneous with respect to plaque size in the presence of aphidicolin).
(ii) No significant fraction of aphidicolin-resistant recombinants retained PAA resistance (i.e. the determinants of PAA resistance were inseparable from the corresponding determinants of aphidicolin hypersensitivity in each of the two parent strains).
(iii) The majority of the aphidicolin-resistant progeny were syn (i.e. if aph~) 9 is the determinant of aphidicolin hypersensitivity in tsD9 and aphh5 the determinant of aphidicolin hypersensitivity in the PAA-resistant derivative of tsB5, then syn is closer to aphb9 than to aphis).
(iv) Recombination between the ts markers was about 18.6 ~o and most ts ÷ progeny were syn ÷ (i.e. syn marker is closer to tsB5 than to tsD9).
(v) The majority of all of the syn ÷ aphidicolin-resistant recombinants were ts ÷ whereas the minority or none of the syn aphidicolin-resistant recombinants were ts ÷ (i.e. the order is [synts B 5 ]-[ tsD9-. paab9 . aphb9 ]-[ paab 5 . aphis]).
A similar set of conclusions can be derived from the cross between tsc75 and tsD9 (Table 5) except that the recombination frequency between aphb9(paab9) and aph~75(paarT5) was 0-86%, and that between tsc75 and tsD9 was >i 30%. Moreover, from this cross, the majority ofsyn, aph r recombinants were ts, whilst the majority or all of the syn ÷ . aph r recombinants were ts ÷ and this cross therefore links tsc75 to the syn side of tsD9. This latter result supports our previous data linking the [HFEM] tsLB2 mutation to the syn side of PAA resistance and to tsc75. Crosses 
Frequency of formation of aphidicolin-resistant progeny by recombination between independent hypersensitive strains and the segregation of unselected markers amongst recombinant progeny
Relative efficiency of plaque formation* • 34 "35 .36 "37 "38 .39 .40 "41 .42 .43 .44 .45 • 34 "35 "36 "37 "38 "39 • 40 • 41 • 42 Physical map [co-ordinafes on the P-isomer) Recombination and linkage relationships between selected mutations in HSV-1 genome deduced from previous (top line ; Honess et al., 1980) and present genetic analyses (Table 5 and associated text). Note that the conventions are as previously described (Honess et al., 1980) and that the orders of the markers within parentheses are not deducible from the result given here.
between HSV-I[KOS]tsC4 and tsD9 gave rise to 1 to 1.3 % of ts + recombinants and 1 to 1-3 % of aphidicolin-resistant recombants (i.e. about 2.6% recombination) and the majority or all (i.e. >t 0.70) of aphidicolin-resistant recombinants were ts + and the majority or all of the ts ÷ recombinants were aphidicolin-resistant. These results are summarized, together with previous data on the linkage relationships in this portion of the genome (Honess et al., 1980) , in the lower panel of Fig. 2 . It should be apparent that these results provide proof for the existence of multiple separate sites for independent determinants of aphicolin hypersensitivity and evidence for the very close linkage or identity of PAA resistance determinants or, in the case of tsD9 and tsC4, ts lesions with the corresponding determinants of aphidicolin hypersensitivity. By the inclusion of suitable markers for other genes the independent determinants of aphidicolin hypersensitivity and PAA resistance can be ordered with a high degree of confidence (Fig. 2, lower panel) . The results summarized in Table 6 also reveal a readily measurable fraction of aphidicolinresistant recombinant viruses (about 1.7~ recombination between the most distant markers contributing to the aphidicolin hypersensitivity of the parental viruses). However, the population of aphidicolin-resistant recombinants was heterogeneous, with only about 50~ of the plaques formed in the presence of the drug being of normal size and the remainder being smaller. More significantly, approx. 25 ~ of the aphidicolin-resistant recombinants retained significant residual resistance to PAA. In the combined presence of both drugs only about 10 of doubly resistant viruses were of normal size, the remainder being reduced in size and markedly heterogeneous. From these results we deduce (i) that these parental viruses each contain multiple alterations contributing to both aphidicolin hypersensitivity and PAA resistance, (ii) that there are determinants of PAA resistance independent of the determinants of aphidicolin hypersensitivity, (iii) that multiple determinants of PAA resistance are located between the most distant determinants of PAA resistance which determine aphidicolin hypersensitivity and, (iv) that the major determinant of aphidicolin hypersensitivity contributed by R9C 2 is closer to the syn locus than the major determinant contributed by [HFEM]P18cl.
DISCUSSION
The combined genetic and biochemical results presented in this paper constitute good evidence that the inhibitory effects of aphidicolin on virus replication are mediated via an action on the virus-coded DNA polymerase activity. A considerable literature documenting the activity of aphidicolin as a specific inhibitor of eukaryotic ct-polymerase activities now exists (e.g. Huberman, 1981) and this conclusion is not unexpected. In addition, there are previous reports of the inhibition of HSV growth (Bucknall et al., 1973) and DNA polymerase activity by aphidicolin (Pedrali-Noy & Spadari, 1979 Dicioccio et al., 1980) . However, detailed studies of the mode of action of this interesting inhibitor on cellular ~-polymerases are likely to be constrained by the difficulties of acquiring the relevant genetic information. Although the inhibitor in its present form seems unlikely to be a useful agent for the treatment of herpesvirus infections (O'Hare & Honess, 1983; present Table 1 and Fig. 1 ; at least one strain of pseudorabies virus also plaques and grows efficiently in the presence of 0-5 Ixg/ml, unpublished results) the HSV DNA polymerase provides an excellent system with which to explore the molecular genetics of aphidicolin resistance, sensitivity and hypersensitivity in a replicative DNA polymerase. Moreover, aphidicolin appears to provide a very sensitive probe for the state of a number of residues in a functionally significant portion of the virus enzyme. The exploitation of this observation should facilitate studies on the structure and functions of this enzyme and, in particular, its interaction with substrate and substrate analogues and studies of changes affecting its interaction with therapeutically useful inhibitors (e.g. acycloguanosine, bromovinyldeoxyuridine).
The survey of a range of supposedly 'wild-type' virus isolates and of the mutants and variants derived from laboratory strains revealed a wide range of aphidicolin resistance phenotypes. However, at least two independent ts mutations in the polymerase locus resulted in aphidicolin hypersensitivity and the selection of mutants resistant to PAA or acycloguanosine very commonly resulted in changes to increased aphidicolin sensitivity or to hypersensitivity. Coen et al. (1983 a) have recently shown that aphidicolin hypersensitivity is also a common consequence of selection for mutations to arabinosyladenosine resistance, and Bastow et al. (1983) have noted that a number of phosphonoformate-resistant mutants of HSV-1 are aphidicolin-sensitive orhypersensitive. The observation that selection for resistance to one analogue or inhibitor can affect sensitivity to others is obviously not novel (see e.g. Table 1 and references therein); however, the degree of the co-selection is in the present case more striking than is usual and the hypersensitive phenotype is readily amenable to genetic analysis. Thus, we have shown that amongst independently derived aphidicolin-hypersensitive variants which are in 'non-selected' (e.g. ts mutant) viruses, or which are the product of limited PAA selection, then aphidicolin hypersensitivity is typically co-determined by the determinant of the ts or PAA resistance phenotypes (i.e. they co-revert on selection for either phenotype and they cannot be separated by recombination, Tables 4 and 5) . Moreover, independently derived changes which determine hypersensitivity can be separated by distances sufficient to permit more than 2~ recombination to form aphidicolin-resistant progeny (see below). The HSV-I[HFEM]P18cl variant was the product of 18 sequential passages in the presence of progressively increasing doses of PAA and during this passage series multiple mutations to PAA resistance were known to have occurred (Honess & Watson, 1977) . Selection for an aphidicolin-resistant derivative of this hypersensitive strain did not have any obvious effect on the initial PAA resistance character of the variant and aphidicolin-resistant recombinants with differing levels of PAA resistance were formed in crosses with this hypersensitive strain. Thus, whilst many independent residues selected for reduced binding of PAA will frequently mediate strong interactions with aphidicolin, there are configurations of variable residues which can confer resistance to all three drugs. There are also configurations at some sites which permit independent determination of a single resistance/sensitivity phenotype. Thus, the present and previous observations (see Introduction) lead to the general suggestion that resistance to PAA (or PFA, ACG, AraA, etc.) and hypersensitivity or resistance to aphidicolin may each be determined by the nature of residues at a constellation of sites which are separated by significant distances within the polymerase locus.
In Fig. 2 we present some of the available information on the physical locations of certain of the markers we have used in the present study (upper panel) together with results from previous (Honess et al., 1980) and the present series of recombination and linkage experiments (lower panel). The results for the locations of tsN20, tsO22 and tsD9 were based on the results of Coen and Schaffer and their colleagues and these workers have also shown that the aphidicolin hypersensitivity of the tsD9 mutant is 'corrected' by sequences within the same co-ordinates as those which restore the ts and PAA resistance characters of this mutant to the 'wild-type' phenotypes (D. M. Coen & P.A. Schaffer, personal communication) . The recombination frequencies we have observed in the present study are consistent with the order and physical data on the separation of markers within the polymerase gene. However, they also permit the ordering and orientation of a number of independent determinants of PAA resistance and aphidicolin hypersensitivity relative to outside markers and to other polymerase lesions such as the tsD9 mutation (e.g. [syn-tsB5]-[tsD9.paab9. aph~9]-[paa[35, aphis] ). The definition of a reliable order of phenotypically interesting mutations is of obvious value for the interpretation of the results of DNA sequence analysis of wild-type and mutant polymerase genes. Obtaining error-free sequences of 3000 to 4000 nucleotides is hardly a trivial undertaking and in such a large gene the probability of irrelevant clonal variations in sequence must also be quite high (note Table 1 ; see also Swain & Galloway, 1983) . Recombination frequences of at least 2~o have been observed within the HSV TK locus (1000 nucleotides; Smiley et al., 1980) and the syn-tsB5 distance in the gA/gB gene (De Luca et aL, 1982) permits some 5.5~ recombination (Fig. 2) , suggesting that the separation between the most distant determinants of PAA resistance and aphidicolin hypersensitivity is likely to be many hundreds of nucleotides. We do not know if these observations indicate the existence of multiple spatially separated domains on the polymerase polypeptide which each interact with these inhibitors and analogues or whether these widely separated changes in the polypeptide chain are folded into a contiguous portion of the three-dimensional structure of the active polymerase. Precedents are not scarce for the latter explanation.
Finally, two observations are yet to be interpreted clearly: the altered aphidicolin sensitivity of some ts mutants which do not appear to be in the known DNA polymerase gene (e.g. [Kos]-tsA1, [HFEM]tsB1) and the increased aphidicolin resistance of a subset ofsyn mutants in HSVl[Kos] and HSV-I[mP17]. It is reasonable to expect that the functionally relevant form of the DNA polymerase will be as part of an integrated complex of replicative proteins. Evidence that the polymerase is not functionally monomeric has been provided by examples of interallelic complementation between ts mutants and PAA resistance markers (Honess & Watson, 1977; Purifoy & Powell, 1981 ; Honess, 1981) . Moreover, Powell and his collaborators (Littler et al., 1983) have shown that there can be pleiotropic effects of mutations in the major DNA-binding protein on the functional stability of the virus DNA polymerase and DNase activities in vivo. We have noted elsewhere that the introduction of the PAA resistance character into tsB1 modified its temperature sensitivity and that the tsN103 mutant shows a small unselected increase in PAA resistance relative to its ts + parent (Honess et al., 1980) . A detailed examination of these more subtle effects may extend the utility of aphidicolin resistance phenotypes beyond the polymerase gene product to monitoring its interactions with other products of other genes.
